Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism
Authors
Keywords
-
Journal
ANTIOXIDANTS & REDOX SIGNALING
Volume 14, Issue 12, Pages 2347-2360
Publisher
Mary Ann Liebert Inc
Online
2011-01-22
DOI
10.1089/ars.2010.3731
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
- (2014) N. G. Innamorato et al. JOURNAL OF IMMUNOLOGY
- Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
- (2010) Malin von Otter et al. BMC Medical Genetics
- Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells
- (2010) Y. Li et al. CLINICAL CANCER RESEARCH
- Celecoxib activates PI-3K/Akt and mitochondrial redox signaling to enhance heme oxygenase-1-mediated anti-inflammatory activity in vascular endothelium
- (2010) Shahir S. Hamdulay et al. FREE RADICAL BIOLOGY AND MEDICINE
- Analysis and Anti-Helicobacter Activity of Sulforaphane and Related Compounds Present in Broccoli (Brassica oleracea L.) Sprouts
- (2010) Joon-Kwan Moon et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1
- (2010) Nadia G. Innamorato et al. PLoS One
- Stress-Activated Cap'n'collar Transcription Factors in Aging and Human Disease
- (2010) G. P. Sykiotis et al. Science Signaling
- The rise of antioxidant signaling—The evolution and hormetic actions of Nrf2
- (2010) Jonathan Maher et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Role of microglial redox balance in modulation of neuroinflammation
- (2009) Nadia G Innamorato et al. CURRENT OPINION IN NEUROLOGY
- The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease
- (2009) Antonio Cuadrado et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The Nrf2–ARE cytoprotective pathway in astrocytes
- (2009) Marcelo R. Vargas et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Nrf2 promotes neuronal cell differentiation
- (2009) Fei Zhao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease
- (2009) Ana I. Rojo et al. GLIA
- Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
- (2009) Pei-Chun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents
- (2009) Larry G. Higgins et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Iron, the substantia nigra and related neurological disorders
- (2008) Amanda M. Snyder et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates
- (2008) Roderick H Dashwood et al. NUTRITION REVIEWS
- Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
- (2008) J. Salazar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started